Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H19NO2 |
Molecular Weight | 257.3276 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
InChI
InChIKey=QNMGHBMGNRQPNL-UHFFFAOYSA-N
InChI=1S/C16H19NO2/c1-17(2)13-16(18-14-9-5-3-6-10-14)19-15-11-7-4-8-12-15/h3-12,16H,13H2,1-2H3
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2253668
After an overnight fast, ascending doses of 200, 500, 750 and 1000 mg of medifoxamine were taken orally
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66884
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
||
|
NCI_THESAURUS |
C47794
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
||
|
WHO-VATC |
QN06AX13
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
||
|
WHO-ATC |
N06AX13
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
MEDIFOXAMINE
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
36109
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
100000081990
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
29434
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | RxNorm | ||
|
m7131
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | Merck Index | ||
|
1656
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
CHEMBL85231
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
KWU7C2A1NT
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
C034065
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
251-011-4
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
32359-34-5
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
3759
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
DTXSID80186078
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
DB13219
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
C83914
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY | |||
|
SUB08693MIG
Created by
admin on Fri Dec 15 16:47:22 GMT 2023 , Edited by admin on Fri Dec 15 16:47:22 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)